183 related articles for article (PubMed ID: 2142858)
1. Atrial natriuretic peptide augments forearm capillary filtration in humans.
Groban L; Cowley AW; Ebert TJ
Am J Physiol; 1990 Jul; 259(1 Pt 2):H258-63. PubMed ID: 2142858
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide increases human capillary filtration and venous distensibility.
Ando S; Imaizumi T; Harada S; Hirooka Y; Takeshita A
J Hypertens; 1992 May; 10(5):451-7. PubMed ID: 1317906
[TBL] [Abstract][Full Text] [Related]
3. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
Doorenbos CJ; Blauw GJ; van Brummelen P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic atrial natriuretic peptide reduces human leg capillary filtration.
Watenpaugh DE; Vissing SF; Lane LD; Buckey JC; Firth BG; Erdman W; Hargens AR; Blomqvist CG
J Cardiovasc Pharmacol; 1995 Sep; 26(3):414-9. PubMed ID: 8583783
[TBL] [Abstract][Full Text] [Related]
5. ANP-mediated volume depletion attenuates renal responses in humans.
Ebert TJ; Groban L; Muzi M; Hanson M; Cowley AW
Am J Physiol; 1992 Dec; 263(6 Pt 2):R1303-8. PubMed ID: 1481943
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
[TBL] [Abstract][Full Text] [Related]
7. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure.
Hirooka Y; Takeshita A; Imaizumi T; Suzuki S; Yoshida M; Ando S; Nakamura M
Circulation; 1990 Jul; 82(1):147-53. PubMed ID: 2163779
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide alters neither capillary filtration nor vascular compliance of both skin and skeletal muscle of humans.
Rölleke T; Berke B; Arndt JO
Basic Res Cardiol; 1994; 89(2):192-205. PubMed ID: 8074642
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone effects on transcapillary fluid dynamics.
Stachenfeld NS; Keefe DL; Palter SF
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1319-29. PubMed ID: 11557642
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiologic levels of atrial natriuretic factor do not alter reflex sympathetic control: direct evidence from microneurographic studies in humans.
Roach PJ; Sanders JS; Berg WJ; Mark AL; Ebert TJ; Ferguson DW
J Am Coll Cardiol; 1990 May; 15(6):1318-30. PubMed ID: 2139443
[TBL] [Abstract][Full Text] [Related]
11. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
[TBL] [Abstract][Full Text] [Related]
12. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
Ando K; Ito Y; Ogata E; Fujita T
Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
[TBL] [Abstract][Full Text] [Related]
13. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.
van der Zander K; Houben AJ; Kroon AA; de Leeuw PW
Cardiovasc Res; 1999 Dec; 44(3):595-600. PubMed ID: 10690292
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
Pesonen A; Leppäluoto J; Ruskoaho H
J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of human atrial natriuretic peptide after modified Fontan procedure.
Hiramatsu T; Imai Y; Takanashi Y; Seo K; Terada M; Nakazawa M
Ann Thorac Surg; 1998 Mar; 65(3):761-4. PubMed ID: 9527208
[TBL] [Abstract][Full Text] [Related]
16. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
17. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
Cockcroft JR; Allen MJ; Benjamin N; Webb DJ
J Hum Hypertens; 1989 Feb; 3(1):49-52. PubMed ID: 2542549
[TBL] [Abstract][Full Text] [Related]
18. Role of atrial natriuretic peptide in systemic responses to acute isotonic volume expansion.
Watenpaugh DE; Yancy CW; Buckey JC; Lane LD; Hargens AR; Blomqvist CG
J Appl Physiol (1985); 1992 Oct; 73(4):1218-26. PubMed ID: 1447062
[TBL] [Abstract][Full Text] [Related]
19. Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP.
Lindqvist M; Kahan T; Melcher A; Bie P; Hjemdahl P
Am J Physiol; 1996 Mar; 270(3 Pt 1):E393-9. PubMed ID: 8638683
[TBL] [Abstract][Full Text] [Related]
20. Cardiac output during exercise is related to plasma atrial natriuretic peptide but not to central venous pressure in humans.
Yoshiga C; Dawson EA; Volianitis S; Warberg J; Secher NH
Exp Physiol; 2019 Mar; 104(3):379-384. PubMed ID: 30673144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]